Cargando…
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
BACKGROUND: Design, results, and interpretation of oncology randomised controlled trials (RCTs) have changed substantially over the past decade. In this study, we describe all RCTs evaluating anticancer therapies in haematological cancers published globally during 2014–2017 with comparisons with sol...
Autores principales: | Sengar, Manju, Hopman, Wilma M, Mohyuddin, Ghulam Rehman, Goodman, Aaron M, Gyawali, Bishal, Mukherji, Deborah, Hammad, Nazik, Pramesh, CS, Aggarwal, Ajay, Sullivan, Richard, Booth, Christopher M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310333/ https://www.ncbi.nlm.nih.gov/pubmed/37396096 http://dx.doi.org/10.3332/ecancer.2023.1558 |
Ejemplares similares
-
Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity
por: Wells, J. Connor, et al.
Publicado: (2022) -
Participation of Lower and Upper Middle–Income Countries in Clinical Trials Led by High-Income Countries
por: Rubagumya, Fidel, et al.
Publicado: (2022) -
Delivery of Global Cancer Care: An International Study of Medical
Oncology Workload
por: Fundytus, Adam, et al.
Publicado: (2017) -
Cancer Medicines: What Is Essential and Affordable in India?
por: Sengar, Manju, et al.
Publicado: (2022) -
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
por: Sharma, Shubham, et al.
Publicado: (2021)